Future Virology. 2015;10(2):77-88. As shown in Figure 2A, katsumadain A exhibited a high level of self-FL at concentrations similar to or greater than 10 µM when compared with the background ...
Recent research has provided valuable insights into the susceptibility of influenza viruses to antiviral drugs, particularly neuraminidase inhibitors (NAIs) and the newer polymerase acidic (PA ...
Hosted on MSN1mon
Flu antiviral baloxavir shows promise over other treatments for high-risk patients, shortening symptom durationAntiviral medications such as neuraminidase inhibitors, like oseltamivir (Tamiflu) and zanamivir (Relenza), and endonuclease inhibitors, such as baloxavir (Xofluza), are used to alleviate symptoms ...
Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. Log out ...
The U.S. Department of Health and Human Services announced contract awards for up to 120,000 treatment courses of intravenous antiviral drugs to help treat hospitalized 2009 H1N1 influenza ...
Choreo LLC acquired a new stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) during the fourth quarter, according to the company in its most recent filing with the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback